Back to NORGES BANK NORGES BANK

CRNXCRNX
9 quarters

Position history for NORGES BANKNORGES BANK's holdings in CRINETICS PHARMACEUTICALS IN

NORGES BANK previously held 0 shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$513,000

Total Shares Change

-33,600

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$29.74
0
2023-Q2
Unchanged
149,100
0.0%
$2.7M0.0%$17.81
0
2023-Q1
New
149,100
-
$2.4M0.0%$15.84
36
2022-Q2
Exited
0
-100.0%
$00.0%$18.00
0
2022-Q1
Decreased
25,600
-45.8%
$561,9200.0%$19.00
0
2021-Q4
Increased
47,200
+118.5%
$1.3M0.0%$28.03
41
2021-Q3
Decreased
21,600
-70.3%
$455,0000.0%$20.80
0
2021-Q2
Increased
72,800
+116.7%
$1.4M0.0%$19.15
41
2021-Q1
New
33,600
-
$513,0000.0%$15.44
33

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used